BCYC vs NCLH · rev $1.5M vs P/E 16, rev $4.97B
Bicycle Therapeutics Ltd (BCYC) versus Norwegian Cruise Line Holdings Ltd (NCLH) — a side-by-side from cached financials, not a winner call.
Bicycle Therapeutics Ltd (BCYC) is a biotechnology company listed on US.
Norwegian Cruise Line Holdings Ltd (NCLH) is a travel services company listed on NYSE.
Latest reported BCYC revenue for 2026-06-30 was $1.5M. Net income was -$111.2M. Revenue was up 70.9% from 2026-03-31 to 2026-06-30. BCYC currently screens at market cap $554.0M.
Latest reported NCLH revenue for 2026-06-30 was $4.97B. Net income was $327.2M. NCLH currently screens at market cap $9.10B and trailing P/E 16.0.
BCYC currently screens at market cap $554.0M. NCLH currently screens at market cap $9.10B and trailing P/E 16.0.
Not investment advice. Open the BCYC and NCLH stock pages for the full models.
Not investment advice.